Copyright
©The Author(s) 2020.
World J Stem Cells. Jan 26, 2020; 12(1): 87-99
Published online Jan 26, 2020. doi: 10.4252/wjsc.v12.i1.87
Published online Jan 26, 2020. doi: 10.4252/wjsc.v12.i1.87
Figure 4 HIF-2α silencing reduces the CD44+/CD24− population in MDA-MB-231 cells.
Flow cytometry of the stem cell-associated cell surface markers CD44 and CD24 in hypoxia and HIF-2α-siRNA treated cells. HIF-2α: Hypoxia-inducible factor-2α.
- Citation: Bai J, Chen WB, Zhang XY, Kang XN, Jin LJ, Zhang H, Wang ZY. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling. World J Stem Cells 2020; 12(1): 87-99
- URL: https://www.wjgnet.com/1948-0210/full/v12/i1/87.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i1.87